Eir Partners has announced a growth investment in Porter, a healthcare technology platform focused on enhancing care coordination and outcomes for patients across the United States.
Target Information
Porter, a pioneering platform in healthcare technology, specializes in connecting plan members with essential resources, services, products, and educational tools to enhance their home care experience. Under the leadership of John Criswell, a seasoned entrepreneur in healthcare technology, Porter addresses the complexities of the healthcare system that often hinder quality care for patients and plan members. Criswell's vision for Porter is to simplify these challenges through innovative technology solutions.
Headquartered in Baltimore, Porter stands out as the sole care coordination program focused on quality and risk adjustment. Utilizing advanced technology and AI, the platform enhances care coordination, removes barriers to follow-up treatments, and ultimately improves patient outcomes while ensuring compliance with risk adjustment programs. Porter's services are available nationwide, catering to members from diverse backgrounds with varying health conditions.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare technology sector in the United States is rapidly evolving, driven by the growing demand for innovative solutions that enhance patient care and streamline healthcare processes. As healthcare costs continue to rise and
Similar Deals
New Mountain Capital → Smarter Technologies
2025
Advantage Capital → Gravity Diagnostics
2025
Ampersand Capital Partners → Lexington Medical
2025
Ampersand Capital Partners → Gannet BioChem
2025
WestView Capital Partners → PharmaLink
2025
General Atlantic → U.S. Urology Partners
2025
Eir Partners
invested in
Porter
in 2025
in a Growth Equity & Expansion Capital deal